Evaluation of four commercially availabl
โ
Vicki D. Christenson; Diane H. White
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 432 KB
We evaluated four commercially available ELlSAs for detection of antibody to Borrelia burgdorferi with 21 sera from patients with clinically diagnosed Lyrne disease and 89 patient control sera. Patient control sera included 28 sera from patients with rheumatoid arthritis (RA), 17 sera from patients